Literature DB >> 22142817

Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma.

Jianjun Jia1, Zineng Wang, Xiaomao Li, Zhixin Wang, Xiaoyu Wang.   

Abstract

OBJECTIVE: The purpose of this study was to investigate changes of the antigen-presenting function of tumor infiltrating dendritic cells (TIDCs) in human endometrioid adenocarcinoma. STUDY
DESIGN: The TIDCs from 45 cases of endometrioid adenocarcinoma were compared with 20 cases of normal human endometrial tissue, using transmission electron microscopic examination, and the expression of CD80, CD86, and CD40 was analyzed by flow cytometry.
RESULTS: In comparison with the control group, the ultrastructure of TIDCs in human endometrioid adenocarcinoma showed the following differences: numerous TIDCs were small in volume and round in shape but some were oval and multi-angular. The cytoplasmic processes were obviously decreased in number and stubbed. Round primary lysosomes with high electron-dense granules, and secondary lysosomes with high or low electron-dense granules were seen frequently in the cytoplasm. TIDCs contained much rough endoplasmic reticulum (RER). Vacuoles with flocculent electron-dense granules were rare. High electron-dense contents in the granules were near one side and the other side was bright. The nucleus became markedly small in volume, nephroid or hoofed in shape. The nucleus had little euchromatin and lots of heterochromatin under the nuclear membrane. The levels of expression of CD80, CD86 and CD40 on TIDCs were low or even nonexistent. The expression levels of CD80, CD86 and CD40 on DCs in human normal endometrium were significantly higher than those on TIDCs in endometrioid adenocarcinoma.
CONCLUSION: It is suggested that morphological differences and low expression of co-stimulatory molecules on TIDCs in endometrioid adenocarcinoma reflected the functional changes of the TIDCs in uptake, processing and presenting antigen, which may lead to the occurrence of tumor immune escape. Crown
Copyright © 2011. Published by Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22142817     DOI: 10.1016/j.ejogrb.2011.11.020

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  4 in total

1.  Epidermal growth factor receptor and B7-H3 expression in esophageal squamous tissues correlate to patient prognosis.

Authors:  Jianxiang Song; Woda Shi; Yajun Zhang; Mingzhong Sun; Xiaodong Liang; Shiying Zheng
Journal:  Onco Targets Ther       Date:  2016-10-12       Impact factor: 4.147

2.  A biomimetic nanoparticle-enabled toxoid vaccine against melittin.

Authors:  Tianyi Kang; Chenyang Li; Ting Du; Yujiao Wu; Yuping Yang; Xuan Liu; Qianqian Zhang; Xiaoping Xu; Maling Gou
Journal:  Int J Nanomedicine       Date:  2018-06-01

3.  Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.

Authors:  Xin-Ying Zhou; Hai-Yan Dai; Hu Zhang; Jian-Long Zhu; Hua Hu
Journal:  Biomed Res Int       Date:  2022-07-28       Impact factor: 3.246

4.  Edible Oxya chinensis sinuosa-Derived Protein as a Potential Nutraceutical for Anticancer Immunity Improvement.

Authors:  Woo Sik Kim; Jeong Moo Han; Ha-Yeon Song; Eui-Hong Byun; Ho Seong Seo; Eui-Baek Byun
Journal:  Nutrients       Date:  2020-10-22       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.